The MarketWatch News Department was not involved in the creation of this content. Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Dec. 11, 2025 /PRNewswire/ -- Equity Insider News Commentary -- ...
Benefits seen from embracing platform technologies, combined with the role such systems played during the pandemic, are key dynamics.
FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision
The Draft Guidance emphasizes up front that the requirement that the platform technology has the potential to be incorporated in, or utilized by, more than one drug excludes some technologies that the ...
In newly released Draft Guidance from the U.S. Food and Drug Administration (FDA) entitled, Platform Technology Designation Program for Drug Development, the FDA addresses its new designation program ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback